创新药基金霸屏“翻倍基” 机构预判创新药企价值重估

中国经营网
Aug 09, 2025

8月5日,君实生物(1877.HK)以33.75%的涨幅收盘,再度让港股创新药板块热度激增,相关主题基金也受到市场持续关注。据Wind数据统计,截至8月5日,港股创新药主题基金、指数基金霸屏“翻倍基”榜单。在港股创新药行情持续火热下,近期有多只指数产品相继上市。不过,在前期积累较大涨幅后,港股创新药近日迎来高位波动。港股通创新药指数在7月30日盘中冲高回落后出现连续调整,到8月4日区间最大回撤达到...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10